[ad_1]
Colgate-Palmolive Firm (NYSE:CL) is included among the many 15 Dividend Shares that Have Raised Payouts for 20+ Years.
Colgate-Palmolive Firm (NYSE:CL) is down by practically 14%, which has made analysts anxious about its outlook.
On October 10, JPMorgan has decreaseed its price target for Colgate-Palmolive Firm (NYSE:CL) from $95 to $88 whereas retaining an Obese score on the stocokay ahead of the company’s third-quarter 2025 earnings launch.
The consumer merchandise leader is about to report its Q3 results on Friday, October 31, earlier than the market opens. JPMorgan attributed the lowered worth target to softer carry outance throughout product categories. Though Colgate-Palmolive Firm (NYSE:CL) maintained its general full-year 2025 steerage for each income and earnings, the company now expects organic gross sales development to land at the lower finish of its beforehand professionaljected 2% to 4% vary as a result of weaker category tendencies.
Nevertheless, several constructive factors have helped steadiness these headwinds. Extra favorable overseas exchange situations have allowed administration to reaffirm its outlookay for low-single-digit internet gross sales development. In addition, whereas tariff-related prices have improved by $125 million, now expected to whole round $75 million, these financial savings are largely offset by greater bills for raw and packaging materials.
Regardless of these near-term pressures, Colgate-Palmolive Firm (NYSE:CL) stays a reliable income inventory, as the corporate has been rising its dividends for 62 consecutive years. The corporate presents a quarterly dividend of $0.52 per share for a dividend yield of two.66%, as of October 16.
Whereas we acknowledge the potential of CL as an funding, we imagine sure AI shares provide better upside potential and carry much less draw back danger. Should you’re on the lookout for a particularly undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.
READ NEXT: 12 Should-Purchase Dividend Shares to Put money into and 11 Defensive Healthcare Dividend Shares To Purchase Now.
Disclosure: None.
[ad_2]
